Immunogenicity and protection induced by a Mycobacterium tuberculosis sigE mutant in a BALB/c mouse model of progressive pulmonary tuberculosis

Infection and Immunity

Volumn 78, Issue 7, 2010, Pages 3168-3176

  Pando, Rogelio Hernandez ^a   Aguilar, Leon Diana ^a   Smith, Issar ^b   Manganelli, Riccardo ^c  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; BETA DEFENSIN; CYTOKINE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; LIVE VACCINE; SIGMA FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COUNT; BACTERIUM MUTANT; BAGG ALBINO MOUSE; IMMUNITY; IMMUNOGENICITY; LUNG; LUNG TUBERCULOSIS; MALE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE; TISSUE INJURY;

ANIMALS; BACTERIAL PROTEINS; BETA-DEFENSINS; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; INTERFERON-GAMMA; LUNG; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MYCOBACTERIUM TUBERCULOSIS; NITRIC OXIDE SYNTHASE; POLYMERASE CHAIN REACTION; SIGMA FACTOR; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77953956583     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00023-10     Document Type: Article

References (39)

1. Aguilar, D., E. Infante, C. Martin, E. Gormley, B. Gicquel, and R. Hernandez Pando. 2007. Immunological responses and protective immunity against tuberculosis conferred by vaccination of Balb/C mice with the attenuated Mycobacterium tuberculosis (phoP) SO2 strain. Clin. Exp. Immunol. 147:330-338.
2. Aguilar, L. D., E. Infante, M. V. Bianco, A. Cataldi, F. Bigi, and R. H. Pando. 2006. Immunogenicity and protection induced by Mycobacterium tuberculosis mce-2 and mce-3 mutants in a Balb/c mouse model of progressive pulmonary tuberculosis. Vaccine 24:2333-2342.
3. Ando, M., T. Yoshimatsu, C. Ko, P. J. Converse, and W. R. Bishai. 2003. Deletion of Mycobacterium tuberculosis sigma factor E results in delayed time to death with bacterial persistence in the lungs of aerosol-infected mice. Infect. Immun. 71:7170-7172.
4. Behr, M. A., M. A. Wilson, W. P. Gill, H. Salamon, G. K. Schoolnik, S. Rane, and P. M. Small. 1999. Comparative genomics of BCG vaccines by wholegenome DNA microarray. Science 284:1520-1523.
5. Browning, D. F., and S. J. Busby. 2004. The regulation of bacterial transcription initiation. Nat. Rev. Microbiol. 2:57-65.
6. Castillo-Rodal, A. I., M. Castanon-Arreola, R. Hernandez-Pando, J. J. Calva, E. Sada-Diaz, and Y. Lopez-Vidal. 2006. Mycobacterium bovis BCG substrains confer different levels of protection against Mycobacterium tuberculosis infection in a BALB/c model of progressive pulmonary tuberculosis. Infect. Immun. 74:1718-1724.
7. Cooper, A. M., D. K. Dalton, T. A. Stewart, J. P. Griffin, D. G. Russell, and I. M. Orme. 1993. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J. Exp. Med. 178:2243-2247.
8. Dona, V., S. Rodrigue, E. Dainese, G. Palu, L. Gaudreau, R. Manganelli, and R. Provvedi. 2008. Evidence of complex transcriptional, translational, and posttranslational regulation of the extracytoplasmic function sigma factor SigE in Mycobacterium tuberculosis. J. Bacteriol. 190:5963-5971.
9. Durr, M., and A. Peschel. 2002. Chemokines meet defensins: the merging concepts of chemoattractants and antimicrobial peptides in host defense. Infect. Immun. 70:6515-6517.
10. Dye, C., S. Scheele, P. Dolin, V. Pathania, and M. C. Raviglione. 1999. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282:677-686.
11. Fine, P. E. 1995. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346:1339-1345.
12. Fontan, P., and I. Smith. 2009. M. tuberculosis SigE protects against environmental stress, immune response. Microbe 4:119-123.
13. Fontan, P. A., V. Aris, M. E. Alvarez, S. Ghanny, J. Cheng, P. Soteropoulos, A. Trevani, R. Pine, and I. Smith. 2008. Mycobacterium tuberculosis sigma factor E regulon modulates the host inflammatory response. J. Infect. Dis. 198:877-885.
14. Giacomini, E., A. Sotolongo, E. Iona, M. Severa, M. E. Remoli, V. Gafa, R. Lande, L. Fattorini, I. Smith, R. Manganelli, and E. M. Coccia. 2006. Infection of human dendritic cells with a Mycobacterium tuberculosis sigE mutant stimulates production of high levels of interleukin-10 but low levels of CXCL10: impact on the T-cell response. Infect. Immun. 74:3296-3304.
15. Gioffre, A., E. Infante, D. Aguilar, M. P. Santangelo, L. Klepp, A. Amadio, V. Meikle, I. Etchechoury, M. I. Romano, A. Cataldi, R. P. Hernandez, and F. Bigi. 2005. Mutation in mce operons attenuates Mycobacterium tuberculosis virulence. Microbes Infect. 7:325-334.
16. Hernandez Pando, R., L. D. Aguilar, E. Infante, A. Cataldi, F. Bigi, C. Martin, and B. Gicquel. 2006. The use of mutant mycobacteria as new vaccines to prevent tuberculosis. Tuberculosis (Edinb.) 86:203-210.
17. Hernandez-Pando, R., D. Aguilar, M. L. Hernandez, H. Orozco, and G. Rook. 2004. Pulmonary tuberculosis in BALB/c mice with non-functional IL-4 genes: changes in the inflammatory effects of TNF-alpha and in the regulation of fibrosis. Eur. J. Immunol. 34:174-183.
18. Hernandez-Pando, R., H. Orozco, K. Arriaga, A. Sampieri, J. Larriva-Sahd, and V. Madrid-Marina. 1997. Analysis of the local kinetics and localization of interleukin-1 alpha, tumour necrosis factor-alpha and transforming growth factor-beta, during the course of experimental pulmonary tuberculosis. Immunology 90:607-617.
19. Hernandez-Pando, R., H. Orozcoe, A. Sampieri, L. Pavon, C. Velasquillo, J. Larriva-Sahd, J. M. Alcocer, and M. V. Madrid. 1996. Correlation between the kinetics of Th1, Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis. Immunology 89:26-33. (Pubitemid 26284034)
20. Hernandez-Pando, R., L. Pavon, K. Arriaga, H. Orozco, V. Madrid-Marina, and G. Rook. 1997. Pathogenesis of tuberculosis in mice exposed to low and high doses of an environmental mycobacterial saprophyte before infection. Infect. Immun. 65:3317-3327.
21. Infante, E., L. D. Aguilar, B. Gicquel, and R. H. Pando. 2005. Immunogenicity and protective efficacy of the Mycobacterium tuberculosis fadD26 mutant. Clin. Exp. Immunol. 141:21-28.
22. Jarnagin, J. L., and D. W. Luchsinger. 1980. The use of fluorescein diacetate and ethidium bromide as a stain for evaluating viability of mycobacteria. Stain Technol. 55:253-258.
23. Lelievre, E., D. Sarrouilhe, F. Morel, J. L. Preud'Homme, J. Wijdenes, and J. C. Lecron. 1998. Preincubation of human resting T cell clones with interleukin 10 strongly enhances their ability to produce cytokines after stimulation. Cytokine 10:831-840. (Pubitemid 29002735)
24. Lopez, B., D. Aguilar, H. Orozco, M. Burger, C. Espitia, V. Ritacco, L. Barrera, K. Kremer, R. Hernandez-Pando, K. Huygen, and D. van Soolingen. 2003. A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes. Clin. Exp. Immunol. 133:30-37.
25. Manca, C., M. B. Reed, S. Freeman, B. Mathema, B. Kreiswirth, C. E. Barry III, and G. Kaplan. 2004. Differential monocyte activation underlies strain-specific Mycobacterium tuberculosis pathogenesis. Infect. Immun. 72:5511-5514.
26. Manganelli, R., E. Dubnau, S. Tyagi, F. R. Kramer, and I. Smith. 1999. Differential expression of 10 sigma factor genes in Mycobacterium tuberculosis. Mol. Microbiol. 31:715-724.
27. Manganelli, R., L. Fattorini, D. Tan, E. Iona, G. Orefici, G. Altavilla, P. Cusatelli, and I. Smith. 2004. The extra cytoplasmic function sigma factor SigE is essential for Mycobacterium tuberculosis virulence in mice. Infect. Immun. 72:3038-3041.
28. Manganelli, R., R. Provvedi, S. Rodrigue, J. Beaucher, L. Gaudreau, and I. Smith. 2004. Sigma factors and global gene regulation in Mycobacterium tuberculosis. J. Bacteriol. 186:895-902.
29. Manganelli, R., M. I. Voskuil, G. K. Schoolnik, and I. Smith. 2001. The Mycobacterium tuberculosis ECF sigma factor SigE: role in global gene expression and survival in macrophages. Mol. Microbiol. 41:423-437.
30. Pablos-Mendez, A., M. C. Raviglione, A. Laszlo, N. Binkin, H. L. Rieder, F. Bustreo, D. L. Cohn, C. S. Lambregts-van Weezenbeek, S. J. Kim, P. Chaulet, and P. Nunn. 1998. Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N. Engl. J. Med. 338:1641-1649.
31. Provvedi, R., F. Boldrin, F. Falciani, G. Palu, and R. Manganelli. 2009. Global transcriptional response to vancomycin in Mycobacterium tuberculosis. Microbiology 155:1093-1102.
32. Rivas-Santiago, B., E. Sada, V. Tsutsumi, D. Aguilar-Leon, J. L. Contreras, and R. Hernandez-Pando. 2006. β-Defensin gene expression during the course of experimental tuberculosis infection. J. Infect. Dis. 194:697-701.
33. Rodrigue, S., R. Provvedi, P. E. Jacques, L. Gaudreau, and R. Manganelli. 2006. The sigma factors of Mycobacterium tuberculosis. FEMS Microbiol. Rev. 30:926-941.
34. Rook, G. A., K. Dheda, and A. Zumla. 2005. Do successful tuberculosis vaccines need to be immunoregulatory rather than merely Th1-boosting? Vaccine 23:2115-2120.
35. Rook, G. A., R. Hernandez-Pando, K. Dheda, and G. Teng Seah. 2004. IL-4 in tuberculosis: implications for vaccine design. Trends Immunol. 25:483-488. (Pubitemid 39490255)
36. Rook, G. A., R. Hernandez-Pando, and A. Zumla. 2009. Tuberculosis due to high-dose challenge in partially immune individuals: a problem for vaccination? J. Infect. Dis. 199:613-618.
37. Smith, I. 2003. Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin. Microbiol. Rev. 16:463-496.
38. Walters, S. B., E. Dubnau, I. Kolesnikova, F. Laval, M. Daffe, and I. Smith. 2006. The Mycobacterium tuberculosis PhoPR two-component system regulates genes essential for virulence and complex lipid biosynthesis. Mol. Microbiol. 60:312-330.
39. Young, D. B. 2003. Building a better tuberculosis vaccine. Nat. Med. 9:503-504.